Evidence map›Paper›PMID 41322583›Full record

ArticleACS omega2025

The Importance of Denaturing Conditions for Protein and Peptide Quantification by Tryptophan Fluorescence.

Christopher T Desire, Brooke A Dilmetz, Jan Degenhardt, Leigh Donnellan, Mark R Condina, Clifford Young, Peter Hoffmann

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Christopher T DesireFuture Industries Institute, University of South Australia, Adelaide, SA 5095, Australia.
Brooke A DilmetzFuture Industries Institute, University of South Australia, Adelaide, SA 5095, Australia.
Jan DegenhardtFuture Industries Institute, University of South Australia, Adelaide, SA 5095, Australia.
Leigh DonnellanClinical and Health Sciences, University of South Australia, Adelaide, SA 5000, Australia.
Mark R CondinaFuture Industries Institute, University of South Australia, Adelaide, SA 5095, Australia.ORCID https://orcid.org/0000-0002-1375-9820
Clifford YoungFuture Industries Institute, University of South Australia, Adelaide, SA 5095, Australia.ORCID https://orcid.org/0000-0002-3945-286X
Peter HoffmannFuture Industries Institute, University of South Australia, Adelaide, SA 5095, Australia.ORCID https://orcid.org/0000-0001-8493-2208

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tryptophan fluorescence is utilized in the proteomics field to determine protein and peptide content, but without appropriate guidelines for its routine use. Using bovine serum albumin (BSA) and TYK-nu cell samples, we discovered that only sufficiently denatured samples resulted in accurate protein measurements. For BSA, this was achieved with 2% sodium dodecyl sulfate, or by combining other solubilization reagents (8 M urea or 1% sodium deoxycholate) with reducing agents. In contrast, accurate protein readings from TYK-nu cell samples occurred only when sodium dodecyl sulfate was utilized for protein denaturation, irrespective of reducing agent usage. To demonstrate its versatility, tryptophan fluorescence was used to quantify protein and peptide levels during an in-solution digestion of BSA, whereupon the sample dilution step reported a 50% decrease in measurable protein. However, the subsequent enzymatic digestion largely mitigated this outcome. Finally, tryptophan fluorescence and colorimetric protein assays were conducted to calculate conversion factors for BSA and a soy flour sample, which facilitated accurate protein determinations from tryptophan fluorescence readings alone. These studies demonstrate the wide applicability of the tryptophan fluorescence assay for proteomic studies, provided samples are adequately denatured to avoid protein content overestimation.

Identifiers

PMID41322583
PMCPMC12658681

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.